Molecular Testing for Cancer Declined during Pandemic, per AMP Survey
Laboratory staffing and supply shortages are limiting patient access to critical cancer screening tests that guide treatment decisions.
Read MorePosted by Laurie Bonner | Feb 24, 2021 | Cancer, Covid 19, Molecular Diagnostics |
Laboratory staffing and supply shortages are limiting patient access to critical cancer screening tests that guide treatment decisions.
Read MorePosted by Melanie Hamilton-Basich | Feb 23, 2021 | Covid 19 |
Laboratory staff working long hours at Penn State’s Department of Pathology are proud of how they’ve adapted to making do with short supplies and heightened demand during the covid-19 pandemic, reports Penn State Health.
Read MorePosted by Melanie Hamilton-Basich | Feb 23, 2021 | Covid 19 |
SIemens Healthineers’ CoV2Ag obtained CE Mark and is now offered for the Atellica Solution and ADVIA Centaur analyzers.
Read MorePosted by Melanie Hamilton-Basich | Feb 22, 2021 | Covid 19 |
The test uses AnteoTech’s AnteoBind technology to support significantly improved sensitivity, and is the first covid-19 rapid self-test authorized by the FDA.
Read MorePosted by Melanie Hamilton-Basich | Feb 22, 2021 | Covid 19 |
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA.
Read More